| 摘要 |
A method of inhibiting melanoma comprising administering to a human in need thereof an effective amount of a compound having the formula <IMAGE> (I) wherein R1 and R3 are independently hydrogen, henyl; R2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino, or a pharmaceutically acceptable salt of solvate thereof; alone or in combination with one or more melanoma-inhibiting agents.
|
